Molecular pathology of haemophilia B in Turkish patients: identification of a large deletion and 33 independent point mutations

Summary. Heterogeneous mutations in the coagulation factor IX (FIX) gene result in a bleeding tendency known as haemophilia B. The haemophilia B mutation database has a total of 2353 patient entries, including 10 of the estimated 1000 Turkish patients. In this study, a more comprehensive analysis of the molecular pathology of haemophilia B in Turkey revealed one large deletion and 33 point mutations in the FIX gene of 34 unrelated patients. Haplotype analysis using six polymorphic sites showed that the mutations identified in a total of 45 patients occurred on 13 different haplotypes and that each mutation was family specific.

[1]  G. Sarkar,et al.  Dideoxy fingerprinting (ddE): a rapid and efficient screen for the presence of mutations. , 1992, Genomics.

[2]  S S Sommer,et al.  Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements. , 1991, American journal of human genetics.

[3]  I. Peake,et al.  Facile and rapid analysis of three DNA polymorphisms within the human factor IX gene using the polymerase chain reaction , 1991, British journal of haematology.

[4]  D. Bowen,et al.  The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin , 1991, British journal of haematology.

[5]  A. Thompson,et al.  The factor IX BamHI polymorphism: T-to-G transversion at the nucleotide sequence-561 , 1989, Human Genetics.

[6]  S. Lord,et al.  The Malmö polymorphism of factor IX: establishing the genotypes by rapid analysis of DNA. , 1989, Blood.

[7]  D. G. Rees,et al.  DETECTION OF POLYMORPHISMS AT CYTOSINE PHOSPHOGUANADINE DINUCLEOTIDES AND DIAGNOSIS OF HAEMOPHILIA B CARRIERS , 1989, The Lancet.

[8]  D. Koeberl,et al.  Genomic amplification with transcript sequencing. , 1988, Science.

[9]  K. Kurachi,et al.  Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). , 1985, Biochemistry.

[10]  G. Brownlee,et al.  CHARACTERISATION AND USE OF AN INTRAGENIC POLYMORPHIC MARKER FOR DETECTION OF CARRIERS OF HAEMOPHILIA B (FACTOR IX DEFICIENCY) , 1984, The Lancet.

[11]  S. Shapiro,et al.  The pennsylvania hemophilia program 1973–1978 , 1980, American journal of hematology.

[12]  I. Wickings Putting it together. The patient, the purse, and the practice. , 1977, Lancet.

[13]  S. Sommer,et al.  Mutations associated with hemophilia B in Turkish patients , 1997, Human mutation.

[14]  G. Aktuǧlu,et al.  Identification of mutations in four hemophilia B patients of Turkish origin, including a novel deletion of base 6411 , 1994, Human mutation.